Showing results (251-260 of 426) with videos related to

Sort By:
Pageof 43
Human Molecular Genetics|January 27, 2009
Germline CDH1 deletions in hereditary diffuse gastric cancer familiesCarla Oliveira, Janine Senz, Pardeep Kaurah, et al.
The Journal of Molecular Diagnostics : JMD|August 31, 2018
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer PatientsBente Risberg, Dana W Y Tsui, Heather Biggs, et al.
Cell Stem Cell|May 26, 2015
Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell PopulationsNicola K Wilson, David G Kent, Florian Buettner, et al.
Science Signaling|February 1, 2018
SILAC identifies LAD1 as a filamin-binding regulator of actin dynamics in response to EGF and a marker of aggressive breast tumorsLee Roth, Swati Srivastava, Moshit Lindzen, et al.
Communications Biology|April 4, 2020
DNA copy number motifs are strong and independent predictors of survival in breast cancerArne V Pladsen, Gro Nilsen, Oscar M Rueda, et al.
Nature Communications|December 23, 2016
p120-catenin prevents multinucleation through control of MKLP1-dependent RhoA activity during cytokinesisRobert A H van de Ven, Jolien S de Groot, Danielle Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
Regulation of p53 tetramerization and nuclear export by ARCRoger S-Y Foo, Young-Jae Nam, Marc Jason Ostreicher, et al.
The Lancet. Oncology|May 16, 2015
Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trialHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Genome Biology|October 11, 2007
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancerSuet F Chin, Andrew E Teschendorff, John C Marioni, et al.
EMBO Molecular Medicine|June 1, 2018
Dynamics of multiple resistance mechanisms in plasma DNA during EGFR-targeted therapies in non-small cell lung cancerDana Wai Yi Tsui, Muhammed Murtaza, Alvin Seng Cheong Wong, et al.
Pageof 43